55In that regard, Laboratoire Pareva’s standing to bring proceedings, for the purposes of the fourth paragraph of Article 263 TFEU, is not disputed. Laboratoire Pareva is directly concerned by the contested regulation, in that that regulation, first, directly affects its legal situation and, second, leaves no discretion to the addressees entrusted with the task of implementing it, such implementation being purely automatic and resulting from EU rules, without the application of other intermediate rules. Moreover, as the party making an application for approval of an active substance, having submitted the dossier and participated in the evaluation procedure, Laboratoire Pareva is individually concerned by that regulation (see, to that effect, judgment of 19 December 2019, Probelte v Commission, T‑67/18, EU:T:2019:873, paragraph 64).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.